Surescripts Showcases Groundbreaking Technology for Healthcare
Surescripts Showcases Groundbreaking Technology at HIMSS25
At HIMSS25, Surescripts, the nation's leading health information network, is bringing together top industry experts to demonstrate how collaborative innovation is enhancing interoperability and streamlining prior authorization processes. Through these efforts, Surescripts aims to improve patient care by ensuring timely treatment and reducing healthcare costs.
Innovations on Display
Surescripts is introducing several key innovations that will help revolutionize the healthcare landscape:
- Enhancing the prior authorization process, allowing patients to receive their required treatments more swiftly while improving clinician workflows.
- Expanding interoperability through Surescripts Interconnect™, which facilitates participation in the Trusted Exchange Framework and Common Agreement (TEFCA) should Surescripts Health Information Network receive the designation of Qualified Health Information Network (QHIN).
Comments from Leadership
Frank Harvey, CEO of Surescripts, stated, "Collaboration and innovation have been vital to our progress in health intelligence sharing. It's all about securely and seamlessly facilitating the flow of patient information across the healthcare system. At HIMSS25, we will showcase meaningful innovations that address major challenges in healthcare while aligning with our mission to enhance patient safety, reduce costs, and elevate care quality."
Industry Experts Join Surescripts
During the event, Surescripts will partner with industry leaders to share significant achievements and ongoing advances from its recent innovations, which are proving vital to both patients and their caregivers.
Engage at the Surescripts Booth
Visitors can find Surescripts at booth #1338, where they can participate in insightful sessions featuring key contributors from various sectors of healthcare:
- Dr. Andrew Mellin, Vice President and Chief Medical Information Officer, who will be joined by other CMIOs to discuss technology-driven value-based care and the positive impacts of an automated prior authorization process.
- Justin McMartin, Interoperability Affairs Manager, who will elaborate on how advancing interoperability and QHIN participation is crucial for enhancing care quality while keeping costs in check.
- Judy Hatchett, Vice President and Chief Information Security Officer, focusing on the importance of collaborations, such as their recent partnership with CLEAR, to enhance identity verification in prescribing practices.
Presentation Schedule
For Media: Surescripts experts will be available for interviews following all presentations. Please contact the media team to arrange discussions.
Monday Highlights
- Connected Care Through Digital Identity
2:45 p.m. at the Interoperability & HIE Preconference Forum.
Tuesday Sessions
- The Latest Innovations in Prior Authorization
11:00 – 11:30 a.m. at Surescripts booth #1338. - CMIO Insights on Tech-Enabled Value-Based Care
2:00 – 2:30 p.m. at Surescripts booth #1338. - To TEFCA and Beyond
3:30 – 3:50 p.m. at the Exchange Theatre Stage. - Social Hour with Surescripts
4:00 p.m. at Surescripts booth #1338.
Wednesday Events
- Reducing Fraudulent Prescribing with Identity Proofing Technology
11:00 – 11:30 a.m. at Surescripts booth #1338. - QHINs: What’s in It for Me?
2:00 – 2:30 p.m. at Surescripts booth #1338. - The Case for Payer & Provider Insights for Population Health
3:30 – 3:50 p.m. at the Exchange Theatre Stage. - Social Hour with Surescripts
4:00 p.m. at Surescripts booth #1338.
About Surescripts
Surescripts' mission is to facilitate deeper integration of health intelligence sharing to enhance patient safety, reduce costs, and elevate the quality of care experiences. By partnering with healthcare organizations nationwide, Surescripts strives to align efforts towards providing trusted insights that empower healthcare professionals to serve their patients judiciously. For more information, interested parties can visit surescripts.com and follow the company's updates on LinkedIn.
Frequently Asked Questions
What is Surescripts' main focus at HIMSS25?
Surescripts aims to showcase innovative solutions that enhance interoperability and streamline the prior authorization process for better healthcare outcomes.
Who are some of the key leaders speaking at the event?
Notable speakers include Dr. Andrew Mellin, Justin McMartin, and Judy Hatchett, who will discuss various advancements in digital healthcare.
What is the significance of Surescripts Interconnect™?
Surescripts Interconnect™ simplifies participation in the Trusted Exchange Framework, which enhances data exchange among healthcare providers.
Where can attendees find Surescripts at the conference?
Surescripts will be located at booth #1338, inviting attendees to engage in discussions and learn more about their innovations.
What is the overall mission of Surescripts?
Surescripts aims to enhance patient safety, lower healthcare costs, and improve quality care through trusted health intelligence sharing.
About The Author
Contact Olivia Taylor privately here. Or send an email with ATTN: Olivia Taylor as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.